Surgical treatment of cervical esophageal carcinoma: larynx-preserving esophagectomy via tracheal transection approach
WU Peng1, YE Fan1, LIN Renyu1, ZOU Changlin2, LIN Xiaoming3, LI He1
1.Department of Otolaryngology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325015, China; 2.Department of Radiotherapy, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325015, China; 3.Department of Cardiothoracic Surgery, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325015, China
Abstract：Objective: To study the results of larynx-preserving esophagectomy via tracheal transection approach for cervical esophageal carcinoma. Methods: A total of 5 patients with cervical esophageal carcinoma undergoing larynx-preserving esophagectomy in our hospital from 2017 to 2019 were selected. Results: All patients underwent combined thoracic and laparoscopic larynx-preserving esophagectomy via tracheal transection approach. Only one patient developed unilateral vocal cord paralysis after surgery. Two patients developed left pleural effusion and atelectasis after surgery. Gastric acid reflux was observed in all patients, which was significantly improved after drug treatment. No patients had major complications and no deaths during their stay in the hospital. After surgery, 4 patients received radiotherapy or chemotherapy, and 1 patient refused chemoradiotherapy for personal reason. The follow-up time was 2-36 months. Only 1 patient died of tumor recurrence 1 year after surgery. The other 4 cases were all alive, with good recovery of speech and swallowing function. With tracheostomy tube removed, they had no choke, no anastomotic fistula or aspiration pneumonia. Conclusion: The larynx-preserving esophagectomy for cervical esophageal carcinoma via tracheal transection approach, combined with adjuvant chemotherapy or radiotherapy, can obtain safe perioperative recovery
参考文献：
[1] GRASS G D, COOPER S L, ARMESON K, et al. Cervical esophageal cancer: a population-based study[J]. Head Neck, 2015, 37(6): 808-814.
[2] ONG G B, LEE T C. Pharyngogastric anastomosis after oesophago-pharyngectomy for carcinoma of the hypopharynx and cervical oesophagus[J]. Br J Surg, 1960, 48: 193-200.
[3] SHUANGBA H, JINGWU S, YINFENG W, et al. Complication following gastric pull-up reconstruction for advanced hypopharyngeal or cervical esophageal carcinoma: a 20-year review in a Chinese institute[J]. Am J Otolaryngol, 2011, 32(4): 275-278.
[4] 孔雁, 高红梅. 食管癌放射治疗10年生存分析及不同治疗方式的疗效比较[J]. 肿瘤防治研究, 2015, 42(1): 56-61.
[5] KELLEY D J, WOLF R, SHAHA A R, et al. Impact of clinicopathologic parameters on patient survival in carcinoma of the cervical esophagus[J]. Am J Surg, 1995, 170(5): 427-431.
[6] MIYATA H, YAMASAKI M, TAKAHASHI T, et al. Larynx-preserving limited resection and free jejunal graft for carcinoma of the cervical esophagus[J]. World J Surg, 2013, 37(3): 551-557.
[7] OTT K, LORDICK F, MOLLS M, et al. Limited resection and free jejunal graft interposition for squamous cell carcinoma of the cervical oesophagus[J]. Br J Surg, 2009, 96(3): 258-266.
[8] 朱一鸣, 张弘, 倪松, 等. 游离空肠I期重建下咽颈段食管癌术后缺损的短期并发症分析[J]. 临床耳鼻咽喉头颈外科杂志, 2016, 30(4): 259-263.
[9] 林心强, 王挥戈, 张燕, 等. 颈段食管癌手术喉功能保留问题的探讨[J]. 临床耳鼻咽喉头颈外科杂志, 2007, 21(20): 935-938, 941.
[10] 杜晓东, 栾信庸, 雷大鹏, 等. 颈段食管癌的外科治疗[J]. 中国耳鼻咽喉头颈外科, 2005, 12(11): 694-697.
[11] MAKINO T, YAMASAKI M, MIYAZAKI Y, et al. Short- and long-term outcomes of larynx-preserving surgery for cervical esophageal cancer: Analysis of 100 consecutive cases[J]. Ann Surg Oncol, 2016, 23(Suppl 5): 858-865.
[12] JONES A S, ROLAND N J, HAMILTON J, et al. Malignant tumours of the cervical oesophagus[J]. Clin Otolaryngol Allied Sci, 1996, 21(1): 49-53.
[13] OKAMURA A, WATANABE M, IMAMURA Y, et al. Cervicothoracoscopic approach in esophagectomy[J]. Ann Surg Oncol, 2018, 25(1): 333.
[14] MUKHERJI S K, ARMAO D, JOSHI V M. Cervical nodal metastases in squamous cell carcinoma of the head and neck: what to expect[J]. Head Neck, 2001, 23(11): 995-1005.
[15] KOSUGI S, KAWAGUCHI Y, KANDA T, et al. Cervical lymph node dissection for clinically submucosal carcinoma of the thoracic esophagus[J]. Ann Surg Oncol, 2013, 20(12): 4016-4021.
[16] 袁杨, 任光国, 肖波, 等. 颈段食管鳞癌患者淋巴结转移的危险因素、区域与预后[J]. 中华胸心血管外科杂志, 2014, 30(11): 670-672.
[17] 周维安, 史振府, 景尚华, 等. 下咽及颈段食管癌不同修复方法的经验[J]. 中华耳鼻咽喉科杂志, 1995, 30(5): 308-310.
[18] 王红涛, 易琳. 管状胃在胸段食管癌切除术中的临床应用[J]. 中国继续医学教育, 2018, 10(22): 98-99.
[19] YANG H, LIU H, CHEN Y, et al. Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): A phase III multicenter, randomized, open-label clinical trial[J]. J Clin Oncol, 2018, 36(27): 2796-2803.
[20] 郑浩, 汪灏, 唐汉, 等. 新辅助同步放化疗与新辅助化疗治疗局部进展期食管鳞癌的疗效分析[J]. 中华消化外科杂志, 2017, 16(5): 464-468.
[21] 刘大胜. 新辅助同步放化疗联合食管癌切除术治疗胸上段食管癌的效果分析[J]. 中国民康医学, 2020, 32(7): 62-63.
[22] 王镇, 秦建军, 李勇, 等. 从外科视角看可切除颈段食管癌的治疗[J]. 中国胸心血管外科临床杂志, 2020, 27(10): 1217-1222.
[23] DAI K Y, YU Y C, LEU Y S, et al. Neoadjuvant chemoradiotherapy and larynx-preserving surgery for cervical esophageal cancer[J]. J Clin Med, 2020, 9(2): 387
